컨퍼런스 커버리지 | 학술센터 | 킴스온라인

주요메뉴 바로가기
본문 바로가기
하단메뉴 바로가기

최근 해외학술대회의 주요 발표내용을 제공합니다.

컨퍼런스 커버리지

Advances in Inflammatory Bowel Diseases (AIBD) 2025 Annual Conference

08 December - 10 December, 2025, United States

Real-world study supports high-dose IV iron for IBD-associated anaemia

2026-01-08

Real-world evidence shows the efficacy and safety of high-dose intravenous (IV) iron for the treatment of anaemia in individuals with inflammatory bowel disease (IBD), irrespective of inflammatory activity.
Younger women with IBD prone to hip fractures

2026-01-08

Female sex appears to be an independent risk factor for hip fracture among individuals with inflammatory bowel disease (IBD), findings from a nationally representative study suggest.
Obefazimod hits targets in identical trials on active UC

2026-01-08

Two phase III induction trials have demonstrated the efficacy and safety of obefazimod, an oral, first-in-class, small molecule, for the treatment of adults with moderate-to-severe ulcerative colitis (UC).
Prior CD-related abdominal surgery has no bearing on pregnancy outcomes

2026-01-08

In expectant mothers, a history of abdominal surgery for Crohn’s disease (CD) exerts no adverse effect on pregnancy, neonatal, or wound healing outcomes, according to the prospective PIANO study.

1

최근 본 콘텐츠

최근 본 콘텐츠가 없습니다

TOP

주식회사 킴스

주식회사 킴스 | 광고/제휴문의 | 이용약관 | 개인정보처리방침 | 법적 책임의 한계 | 서비스 전체보기

서울특별시 강남구 테헤란로 8길 33 청원빌딩 1층 (주)킴스
개인정보관리책임자 : 최동섭 사업자등록번호 : 214-81-75415 통신판매업신고 : 강남-5166호 대표이사 : 마사키 타카하타
고객센터 : 1544-2930 (10:00~17:00, 주말/공휴일 제외) 팩스 : 02-3019-9380 e-mail : webmaster@kims.co.kr

Copyright © 1987-2026 KIMS Co., Ltd All Rights Reserved

KIMS 페이스북

KIMS 유튜브